The tumor-promoting effect of ASCL1 expression in our study was consistent with previous observations in lung adenocarcinoma, in which ASCL1-positive is accompanied with a poor immune cell infiltration based on both transcriptomic and IHC analyses, thereby mediates its cell-proliferation effect and primarily resistant to immunotherapy (25, 26). This evidence concerns the gene ASCL1 and lung adenocarcinoma.